Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2...

por Abdel-Razeq, Hikmat, Saadeh, Salwa S, Abu-Nasser, Mahmoud, Abdulelah, Hazem, Marie, Lina, Salam, Murad, Ali, Basel Al-Haj, Ibrahim, Mohammad, Rimawi, Dalia
Publicado 2018